VKH
BSTC

Virtu KCG Holdings’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Virtu KCG Holdings’s Portfolio BSTC Stock Details BSTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-4,937
Closed -$225K – 3959
2016
Q3 		$225K Buy
+4,937
New +$198K 0.01% 2259

Other funds holding BSTC

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
ECP
Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Virtu KCG Holdings's BSTC Position: Q4 2016 in Review

Virtu KCG Holdings sold out of BioSpecifics Technologies Corp. (BSTC) in Q4 2016, closing a stake of 4,937 shares — an estimated $225K sold.

Virtu KCG Holdings first reported a position in BSTC in Q3 2016 and held it in 1 quarter. The position peaked at $225K in Q3 2016. 96 funds tracked by Wall St. Rank hold BSTC as of Q4 2016.

  • Virtu KCG Holdings reported no remaining BioSpecifics Technologies Corp. position as of Q4 2016 after selling out during the quarter.
  • Virtu KCG Holdings sold 4,937 BioSpecifics Technologies Corp. shares in Q4 2016, an estimated $225K.
  • Virtu KCG Holdings first reported a position in BioSpecifics Technologies Corp. in Q3 2016 and held it in 1 quarter.
  • Virtu KCG Holdings's BioSpecifics Technologies Corp. position peaked at $225K in Q3 2016.
  • 96 funds tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2016.

Based on Virtu KCG Holdings's 13F filing for Q4 2016, filed 10 Feb 2017.